MENLO PARK, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has joined the 1000 Genomes Long Read ...
Long-read genome sequencing is being integrated early into ASO therapy development to capture complex genetic variants missed ...
MENLO PARK, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced CiFi, a new community-developed method that ...
Researchers are using long-read whole-genome sequencing as a first-line test to study sudden unexplained death in childhood, ...
PacBio received $48.1 million in net cash proceeds from the transaction. Under the terms of the agreement, Illumina assumed certain liabilities and granted a non-exclusive license certain intellectual ...
MENLO PARK, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading provider of high-quality, highly accurate long-read sequencing solutions, today announced that the National Institute on ...
Zacks Investment Research on MSN
PacBio stock up on HiFi sequencing adoption for major SUDC research
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome sequencing technology has been adopted as a first-line approach in a major ...
PacBio reports that through its partnership with China-headquartered Berry Genomics, the Sequel II CNDx system has received Class III Medical Device Registration approval from the National Medical ...
Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.
The National Institute on Aging’s Long Life Family Study (LLFS) selected PacBio technology to generate genomic and epigenomic data from as many as 7,800 participants. The effort will rely on PacBio’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results